Data from a phase III trial of Novartis' Jakavi has found it helps patients with the rare blood cancer, polycythemia vera. The positive results are welcome for Novartis, which should eventually ...

In patients with renal insufficiency associated with increased hemoglobin levels and polycythemia, the possibilities of recombinant erythropoietin overdosing and disorders such as neoplasms and ...

Right now, as I mentioned, our standard therapy for patients with polycythemia vera is to bring them in regularly and drain them of their blood. That is pretty archaic and sounds like something we ...